Mutual Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Sell |
15,545
-753
| -5% | -$66K | 0.03% | 410 |
|
|
2025
Q1 | $1.31M | Sell |
16,298
-621
| -4% | -$49.8K | 0.04% | 379 |
|
|
2024
Q4 | $1.49M | Sell |
16,919
-761
| -4% | -$66.9K | 0.04% | 361 |
|
|
2024
Q3 | $1.72M | Sell |
17,680
-79
| -0.4% | -$7.68K | 0.05% | 310 |
|
|
2024
Q2 | $1.78M | Sell |
17,759
-193
| -1% | -$19.4K | 0.05% | 301 |
|
|
2024
Q1 | $1.7M | Buy |
17,952
+1,395
| +8% | +$132K | 0.05% | 314 |
|
|
2023
Q4 | $1.48M | Sell |
16,557
-1,751
| -10% | -$156K | 0.05% | 338 |
|
|
2023
Q3 | $1.34M | Sell |
18,308
-344
| -2% | -$25.1K | 0.05% | 350 |
|
|
2023
Q2 | $1.55M | Sell |
18,652
-196
| -1% | -$16.3K | 0.06% | 316 |
|
|
2023
Q1 | $1.44M | Sell |
18,848
-633
| -3% | -$48.2K | 0.06% | 328 |
|
|
2022
Q4 | $1.62M | Buy |
19,481
+736
| +4% | +$61.1K | 0.07% | 279 |
|
|
2022
Q3 | $1.49M | Buy |
18,745
+221
| +1% | +$17.5K | 0.08% | 256 |
|
|
2022
Q2 | $1.38M | Buy |
18,524
+4,079
| +28% | +$303K | 0.09% | 261 |
|
|
2022
Q1 | $1.3M | Buy |
14,445
+1,401
| +11% | +$126K | 0.07% | 298 |
|
|
2021
Q4 | $1.46M | Sell |
13,044
-1,886
| -13% | -$211K | 0.08% | 287 |
|
|
2021
Q3 | $1.88M | Buy |
14,930
+2,623
| +21% | +$330K | 0.11% | 227 |
|
|
2021
Q2 | $1.67M | Sell |
12,307
-1,547
| -11% | -$209K | 0.1% | 252 |
|
|
2021
Q1 | $1.88M | Buy |
13,854
+2,014
| +17% | +$273K | 0.13% | 196 |
|
|
2020
Q4 | $1.67M | Sell |
11,840
-3,983
| -25% | -$561K | 0.12% | 198 |
|
|
2020
Q3 | $1.76M | Buy |
15,823
+3,314
| +26% | +$369K | 0.15% | 160 |
|
|
2020
Q2 | $1.4M | Buy |
12,509
+8,844
| +241% | +$990K | 0.14% | 173 |
|
|
2020
Q1 | $284K | Buy |
+3,665
| New | +$284K | 0.04% | 411 |
|